Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255]

A Vogel¹, A Cervantes², I Chau³, B Daniele⁴, J M Llovet⁵, T Meyer⁶, J-C Nault⁷, U Neumann⁸, J Ricke⁹, B Sangro¹⁰, P Schirmacher¹¹, C Verslype¹², C J Zech¹³, D Arnold¹⁴, E Martinelli¹⁵; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Affiliations

¹ Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.
² Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
³ Department of Medicine, Royal Marsden Hospital, Surrey, UK.
⁴ Dipartimento di Oncologia, A. O. G. Rummo, Benevento, Italy.
⁵ Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Mount Sinai Liver Cancer Program, New York, USA; Barcelona-Clínic Liver Cancer Group (BCLC), Unitat d'Hepatologia, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
⁶ Oncology, Royal Free Hospital, London, UK; UCL Cancer Institute, University College London, London, UK.
⁷ Service d'hépatologie, Hôpital Jean Verdier, Bondy, France.
⁸ Klinik für Allgemein- und Viszeralchirurgie, Medizinische Fakultät der RWTH Aachen, Germany.
⁹ Klinik und Poliklinik für Radiologie, Ludwig-Maximilians-Universität München, Munich, Germany.
¹⁰ Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
¹¹ Institute of Pathology, University Hospital, Heidelberg, Germany.
¹² Campus Gasthuisberg, UZ Leuven, Leuven, Belgium.
¹³ Klinik für Radiologie und Nuklearmedizin Universität Basel, Basel, Switzerland.
¹⁴ Department Oncology, Section Hematology and Palliative Care AK Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany.
¹⁵ Faculty of Medicine, Università della Campania L. Vanvitelli Naples, Caserta, Italy.

PMID: 35365377
DOI: 10.1016/j.annonc.2022.03.009

Free article

Published Erratum

Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255]

A Vogel et al. Ann Oncol. 2022 Jun.

Free article

. 2022 Jun;33(6):666.

doi: 10.1016/j.annonc.2022.03.009. Epub 2022 Mar 30.

Authors

Affiliations

¹ Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.
² Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
³ Department of Medicine, Royal Marsden Hospital, Surrey, UK.
⁴ Dipartimento di Oncologia, A. O. G. Rummo, Benevento, Italy.
⁵ Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Mount Sinai Liver Cancer Program, New York, USA; Barcelona-Clínic Liver Cancer Group (BCLC), Unitat d'Hepatologia, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
⁶ Oncology, Royal Free Hospital, London, UK; UCL Cancer Institute, University College London, London, UK.
⁷ Service d'hépatologie, Hôpital Jean Verdier, Bondy, France.
⁸ Klinik für Allgemein- und Viszeralchirurgie, Medizinische Fakultät der RWTH Aachen, Germany.
⁹ Klinik und Poliklinik für Radiologie, Ludwig-Maximilians-Universität München, Munich, Germany.
¹⁰ Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
¹¹ Institute of Pathology, University Hospital, Heidelberg, Germany.
¹² Campus Gasthuisberg, UZ Leuven, Leuven, Belgium.
¹³ Klinik für Radiologie und Nuklearmedizin Universität Basel, Basel, Switzerland.
¹⁴ Department Oncology, Section Hematology and Palliative Care AK Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany.
¹⁵ Faculty of Medicine, Università della Campania L. Vanvitelli Naples, Caserta, Italy.

PMID: 35365377
DOI: 10.1016/j.annonc.2022.03.009

No abstract available

PubMed Disclaimer

Erratum for

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, Schirmacher P, Verslype C, Zech CJ, Arnold D, Martinelli E; ESMO Guidelines Committee. Vogel A, et al. Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308. Ann Oncol. 2018. PMID: 30285213 No abstract available.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255]

Affiliations

Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources